AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...
Shares of Abbott Laboratories advanced 3.74% to $131.35 Thursday, on what proved to be an all-around poor trading session for ...
Developers of cardiology drugs and devices will be back in the spotlight this weekend when the annual scientific meeting of ...
MedPage Today on MSN1d
STRIDE: Semaglutide Shows it Has Legs in Peripheral Artery DiseaseCHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...
The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and ...
The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...
Currently chief information officer at Quest Diagnostics, Fonseca will join Pfizer’s executive leadership team in January. Fonseca previously served as senior vice president at Laboratory ...
Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...
FairJourney Biologics S.A., global leader in antibody discovery and development, today announced the formation of its ...
President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC ...
Times-Standard on MSN1d
COVID-19 five years later | Pandemic shaped ways we combat infectious diseasesThis is the second of two parts about the fifth anniversary since the COVID-19 pandemic began. Dr. James Goldberg, chief ...
EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Reports 2024 Year-End Financial Results and Provides Business Update 27.03.2025 / 21:06 CET/CEST The issuer is solely responsible for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback